Maks Drug Limited's production activities in BSCIC I/A, Konabari, Gazipur, Bangladesh, feature some amazing and up to date machinery that is truly fascinating. With production facilities for APIs, biologics, and formulations, MDL is vertically integrated, providing an effective supply chain and ensuring cost- and quality-control. MDL is dedicated to upholding high standards of quality and simplifying our manufacturing processes to meet the ever-increasing regulatory requirements.
Our core value of passion for excellence drives Maks' research and development. MDL’s R&D department is run by devoted staff members who work around the clock to meet all its requirements. Many curious brains with a passion for finding and developing medications to assist patients live longer, better lives are housed in our development unit. This creative team is engaged in developing new formulations and dosage forms with competitive advantages and strong product differentiation. Their effort is aligned with our enterprise goal — to bring affordable, quality medicines to the market to address unmet patient needs.
MDL plans to construct its modern production plant at BSCIC I/A, Konabari, Gazipur to meet the escalating regulatory requirements of the local and worldwide markets as well as the expanding problems of medical science. This plant will be created for a top consultant in the industry with an eye toward the evolving therapeutic requirements of people today and in the future. These facilities will reflect our unrelenting pursuit of excellence and commitment to our people as well as the people of the world at large. The goal of this manufacturing facility's design is to fulfill cGMP standards internationally, with a focus on the TGA, ISO, WHO, ICH, MHRA and other stringent regulatory bodies. MDL actively and persistently advocates for improving production capabilities through the realization of quality enhancement and low-cost manufacturing. To meet the needs of the population in Bangladesh and around the world, production facilities aim to develop a centralized system of R&D, quality, production, and engineering. In addition to other items, MDL intends to familiarize sterile products to accommodate the various demands of patients and medical professionals.
Excellence in quality extends beyond compliance. It is a guarantee of high-quality treatment. We think that constantly maintaining high levels of quality in all we do is the key to bolstering the basis of a responsible brand. Every aspect of our business operations, including product acquisition, production, distribution, and safe product disposal, is rooted in quality. Enhancing our Quality Management Systems to meet and surpass the current regulatory bodies' requirements has been our main emphasis over the past few years. As part of our commitment to attaining zero-defect production, we enforce stringent quality controls to guarantee that every product that leaves our plant complies with all relevant quality and regulatory standards. We are one of the top partners of choice for international Government and Non-Governmental institutions due to our reputation for continuously producing high-quality products. To guarantee compliance with pertinent quality standards throughout its value chain, we regularly audit our vendors. To keep an eye on quality during clinical trials, tech transfer, and the development of molecules, the Quality by Design (QbD) team and Development Quality Assurance (DQA) team collaborate closely with the R&D function. The Quality Control (QC) team develops and puts into practice strict procedures during the manufacturing process to guarantee quality. Post-manufacturing, this is strengthened by strict pharmacovigilance, safe destruction of faulty and expired goods, and other measures. Thanks to our effective Quality Control systems, we have effectively dealt with issues including escalating regulatory pressures, onerous compliance requirements, and strict quality standards. The business model used by the company has a futuristic outlook and anticipates expected regulatory developments. As a result, we are better equipped to quickly adjust to a changing environment and maintain business continuity.
Our policy calls for the construction of a clean environment that is both safe and healthy for employees and the general public. In terms of plant design, equipment selection, maintenance, and operations, it strives for the highest worldwide standards. At MDL, we are wholly devoted to conducting our business in a way that upholds the highest standards of environmental, health, and safety (EHS). As part of our business culture, the significance of EHS is consistently emphasized and widely promoted. The policy is a commitment on our part to produce our goods in a secure and environmentally friendly manner.